Modus Therapeutics Holding

0.41 SEK

-2.38%

Less than 1K followers

MODTX

First North Stockholm

Biotechnology & Pharmaceuticals

Health Care

Income statement

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Modus Therapeutics Holding

202020212022202320242025
Revenue
growth-%
EBITDA-6.0-20.7-18.0-16.4-15.8-
EBIT-6.0-20.7-18.0-16.4-15.8-18.1
Profit before taxes-6.0-20.7-18.3-17.9-15.8-18.5
Net income-6.0-20.7-18.3-17.9-15.8-18.5
EPS-0.15-0.51-0.45-0.40-0.17-0.30
Dividend0.000.000.000.000.000.00
Dividend ratio-0.0 %-0.0 %-0.0 %-0.0 %-0.0 %-0.0 %

Profitability and return on capital

202020212022202320242025
EBITDA-%
EBIT-%
ROE-86.0 %-131.5 %707.3 %-101.2 %-740.2 %-204.4 %
ROI-80.3 %-97.6 %-162.6 %-89.3 %-324.6 %-146.2 %